Cecilia Oliyai
- Pharmaceutical Science top 10%
-
- Monoclonal and Polyclonal Antibodies Research 2
-
- Protein purification and stability 4
- Chemical Synthesis and Analysis 2
-
- Nanoparticle-Based Drug Delivery 1
-
- Botulinum Toxin and Related Neurological Disorders 3
-
- Peptidase Inhibition and Analysis 2
- Cancer Treatment and Pharmacology 2
-
- Innovative Microfluidic and Catalytic Techniques Innovation 1
- Co-authors
- Ronald T. BorchardtThomas J. LoblAndré TrouetDan ShochatKim Van derpoortenVincent DuboisA. PassioukovJorge Abarca‐Quinones
- Journals
- Journal of Medicinal Chemistry (1 paper)Pharmaceutical Research (3 papers)Toxicon (4 papers)
- Partner nations
- United StatesBelgiumUnited Kingdom
In The Last Decade
Cecilia Oliyai
12 papers receiving 404 citations
Peers
Comparison fields: 5 of 62
- Pharmaceutical Science 44
- Radiology, Nuclear Medicine and Imaging 125
- Molecular Biology 307
- Biomaterials 58
- Spectroscopy 44
Countries citing papers authored by Cecilia Oliyai
This map shows the geographic impact of Cecilia Oliyai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecilia Oliyai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecilia Oliyai more than expected).
Fields of papers citing papers by Cecilia Oliyai
This network shows the impact of papers produced by Cecilia Oliyai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecilia Oliyai. The network helps show where Cecilia Oliyai may publish in the future.
Co-authorship network
The 20 scholars most cited alongside Cecilia Oliyai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 3 | |
| 2 | 2018 | 3 | |
| 3 | 2018 | 8 | |
| 4 | 2018 | 9 | |
| 5 | CPI-0004Na, a new extracellularly tumor-activated prodrug of doxorubicin: in vivo toxicity, activity, and tissue distribution confirm tumor cell selectivity. | 2002 | 26 |
| 6 | Extracellularly tumor-activated prodrugs for the selective chemotherapy of cancer: application to doxorubicin and preliminary in vitro and in vivo studies. | 2001 | 55 |
| 7 | 2001 | 60 | |
| 8 | 1995 | 4 | |
| 9 | 1994 | 45 | |
| 10 | 1994 | 69 | |
| 11 | Solid state chemical instability of an asparaginyl residue in a model hexapeptide. | 1994 | 17 |
| 12 | 1993 | 126 |
About Cecilia Oliyai
Cecilia Oliyai is a scholar working on Neurology, Biophysics and Pharmaceutical Science, having authored 12 papers that have together received 425 indexed citations. Recurring topics across this work include Protein purification and stability (4 papers), Botulinum Toxin and Related Neurological Disorders (3 papers), Chemical Synthesis and Analysis (2 papers), Peptidase Inhibition and Analysis (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Cancer Treatment and Pharmacology (2 papers), Innovative Microfluidic and Catalytic Techniques Innovation (1 paper) and Nanoparticle-Based Drug Delivery (1 paper). The work is most often cited by research in Pharmaceutical Science (44 citations), Radiology, Nuclear Medicine and Imaging (125 citations) and Molecular Biology (307 citations). Cecilia Oliyai has collaborated with scholars based in United States, Belgium and United Kingdom. Frequent co-authors include Ronald T. Borchardt, Thomas J. Lobl, André Trouet, Dan Shochat, Kim Van derpoorten, Vincent Dubois, A. Passioukov, Jorge Abarca‐Quinones, R. Baurain and Sanjeev Gangwar. Their work appears in journals such as Journal of Medicinal Chemistry, Pharmaceutical Research and Toxicon.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.